192 related articles for article (PubMed ID: 27990594)
1. Health care costs of borderline personality disorder and matched controls with major depressive disorder: a comparative study based on anonymized claims data.
Bode K; Vogel R; Walker J; Kröger C
Eur J Health Econ; 2017 Dec; 18(9):1125-1135. PubMed ID: 27990594
[TBL] [Abstract][Full Text] [Related]
2. Population-based cost-offset estimation for the treatment of borderline personality disorder: projected costs in a currently running, ideal health system.
Wunsch EM; Kliem S; Kröger C
Behav Res Ther; 2014 Sep; 60():1-7. PubMed ID: 25014129
[TBL] [Abstract][Full Text] [Related]
3. Cost of borderline personality disorder in Catalonia (Spain).
Salvador-Carulla L; Bendeck M; Ferrer M; Andión O; Aragonès E; Casas M;
Eur Psychiatry; 2014 Oct; 29(8):490-7. PubMed ID: 25174269
[TBL] [Abstract][Full Text] [Related]
4. Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression: A Matched-Cohort Study Using a US Commercial Claims Database.
Amos TB; Tandon N; Lefebvre P; Pilon D; Kamstra RL; Pivneva I; Greenberg PE
J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29474009
[TBL] [Abstract][Full Text] [Related]
5. [Mental health service utilization among borderline personality disorder patients inpatient].
Cailhol L; Thalamas C; Garrido C; Birmes P; Lapeyre-Mestre M
Encephale; 2015 Apr; 41(2):115-22. PubMed ID: 25526809
[TBL] [Abstract][Full Text] [Related]
6. Societal costs of Borderline Personality Disorders: a matched-controlled nationwide study of patients and spouses.
Hastrup LH; Jennum P; Ibsen R; Kjellberg J; Simonsen E
Acta Psychiatr Scand; 2019 Nov; 140(5):458-467. PubMed ID: 31483859
[TBL] [Abstract][Full Text] [Related]
7. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
8. Specificity of abnormal brain volume in major depressive disorder: a comparison with borderline personality disorder.
Depping MS; Wolf ND; Vasic N; Sambataro F; Thomann PA; Christian Wolf R
J Affect Disord; 2015 Mar; 174():650-7. PubMed ID: 25577159
[TBL] [Abstract][Full Text] [Related]
9. Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.
Pilon D; Joshi K; Sheehan JJ; Zichlin ML; Zuckerman P; Lefebvre P; Greenberg PE
PLoS One; 2019; 14(10):e0223255. PubMed ID: 31600244
[TBL] [Abstract][Full Text] [Related]
10. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
Asche CV; Joish VN; Camacho F; Drake CL
Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
[TBL] [Abstract][Full Text] [Related]
11. Cost of post-traumatic stress disorder vs major depressive disorder among patients covered by medicaid or private insurance.
Ivanova JI; Birnbaum HG; Chen L; Duhig AM; Dayoub EJ; Kantor ES; Schiller MB; Phillips GA
Am J Manag Care; 2011 Aug; 17(8):e314-23. PubMed ID: 21851139
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness and Budget Impact of Specialized Psychotherapy for Borderline Personality Disorder: A Synthesis of the Evidence.
Wetzelaer P; Lokkerbo J; Arntz A; van Aselt T; Smit F; Evers S
J Ment Health Policy Econ; 2017 Dec; 20(4):177-190. PubMed ID: 29300704
[TBL] [Abstract][Full Text] [Related]
13. Societal cost-of-illness in patients with borderline personality disorder one year before, during and after dialectical behavior therapy in routine outpatient care.
Wagner T; Fydrich T; Stiglmayr C; Marschall P; Salize HJ; Renneberg B; Fleßa S; Roepke S
Behav Res Ther; 2014 Oct; 61():12-22. PubMed ID: 25113523
[TBL] [Abstract][Full Text] [Related]
14. Common and distinct structural network abnormalities in major depressive disorder and borderline personality disorder.
Depping MS; Wolf ND; Vasic N; Sambataro F; Thomann PA; Wolf RC
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():127-33. PubMed ID: 26382757
[TBL] [Abstract][Full Text] [Related]
15. Regional analysis of health service utilisation by persons with borderline personality disorders: implications for evidence-informed policy.
Ferrer M; Andion O; Bendeck M; Calvo N; Prat M; Aragones E; Barral C; Casas M; Salvador-Carulla L
J Ment Health Policy Econ; 2015 Mar; 18(1):17-25. PubMed ID: 25862205
[TBL] [Abstract][Full Text] [Related]
16. The cost of borderline personality disorder: societal cost of illness in BPD-patients.
van Asselt AD; Dirksen CD; Arntz A; Severens JL
Eur Psychiatry; 2007 Sep; 22(6):354-61. PubMed ID: 17544636
[TBL] [Abstract][Full Text] [Related]
17. The value of psychological treatment for borderline personality disorder: Systematic review and cost offset analysis of economic evaluations.
Meuldijk D; McCarthy A; Bourke ME; Grenyer BF
PLoS One; 2017; 12(3):e0171592. PubMed ID: 28249032
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing bipolar II depression from major depressive disorder with comorbid borderline personality disorder: demographic, clinical, and family history differences.
Zimmerman M; Martinez JH; Morgan TA; Young D; Chelminski I; Dalrymple K
J Clin Psychiatry; 2013 Sep; 74(9):880-6. PubMed ID: 24107761
[TBL] [Abstract][Full Text] [Related]
19. Depression and borderline personality disorder.
Beatson JA; Rao S
Med J Aust; 2013 Sep; 199(6 Suppl):S24-7. PubMed ID: 25370280
[TBL] [Abstract][Full Text] [Related]
20. The burden of disease in patients eligible for mentalization-based treatment (MBT): quality of life and costs.
Laurenssen EM; Eeren HV; Kikkert MJ; Peen J; Westra D; Dekker JJ; Busschbach JJ
Health Qual Life Outcomes; 2016 Oct; 14(1):145. PubMed ID: 27733207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
